Meeting
2024 ASCO Annual Meeting
Identification of patients with DCIS with low-risk clinicopathology who benefit from radiation therapy with and without endocrine therapy after breast-conserving surgery assessed with the 7-gene biosignature.
Authors
Pat W. Whitworth
Nashville Breast Center, Nashville, TN
Pat W. Whitworth , Chirag Shah , Frank Vicini , Rachel Rabinovitch , Julie A. Margenthaler , Fredrik Warnberg , Michael C. Leo , Sheila Weinmann , Bruce Mann , David J. Dabbs , Jess Savala , Steven C. Shivers , Karuna Mittal , Troy Bremer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 528)
DOI
10.1200/JCO.2024.42.16_suppl.528
Abstract #
528
Poster Bd #
120
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ breast cancer from 2001-2016.
First Author: Erin Aiello Bowles
Poster
2021 ASCO Annual Meeting
Role of 21- gene recurrence score in patients age ≥70 with T1N0 ER/PR+ HER2- breast cancer treated with breast-conserving surgery and endocrine therapy.
First Author: Neil Chandrabhan Chevli
Poster
2021 ASCO Annual Meeting
Disparities in surveillance imaging after breast conserving surgery for primary DCIS.
First Author: Danalyn Byng
First Author: A. M. Murphy